Richard Gale, Mahmoud Husseiny Awad, Clare Bailey, Peter Cackett, Ramandeep Chhabra, Louise Downey, Faruque Ghanchi, Ajay Kotagiri, Nirodhini Narendran, Ian Pearce, Tunde Peto, Sobha Sivaprasad, Saad Younis, Jackie Napier, Rose Gilbert, Safeen Ismat
چکیده
Therapies with robust visual outcomes and reduced patient and healthcare system treatment burden are needed amidst the rising incidence of neovascular age-related macular degeneration (nAMD). Aflibercept 8 mg is an additional treatment option with demonstrated potential for extended dosing…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1038/s41433-025-04180-8